Mohamed Derbala, Senior Research Scientist at MD Anderson Cancer Center, shared on X:
“We’re presenting our trial in progress at SITC 2026 in Phoenix: BND-22 in combination with cemiplimab in patients with cholangiocarcinoma.”
SITC 2026 – 41st Annual Meeting and Pre-Conference Programs
SITC 2026 is the 41st Annual Meeting of the Society for Immunotherapy of Cancer (SITC), one of the major international scientific conferences dedicated to cancer immunotherapy.
- November 4-8, 2026
- Phoenix, Arizona, USA
- Focus: Cancer immunotherapy, clinical trials, translational research, and emerging treatments
The conference brings together oncologists, immunologists, researchers, pharmaceutical companies, and other professionals working on new ways to use the immune system to treat cancer.”
Other articles about Cholangiocarcinoma on OncoDaily.